| abstract |
The present invention belongs to the field of pharmaceutical technology, and relates to a solid pharmaceutical composition containing a quinazoline derivative or a pharmaceutically acceptable salt thereof and a method for producing the same, specifically N 6 —( a solid pharmaceutical composition comprising 1-acryloylpiperidin-4-yl)-N 4 -(3-chloro-4-fluorophenyl)-7-methoxyquinazoline-4,6-diamine or a pharmaceutically acceptable salt thereof; It relates to its method of manufacture and its use. |